Clinical Trials Browser

Phase 3 × Has announcements × Purpura, Thrombocytopenic, Idiopathic × Clear all

NCT02077192 2023-12-11

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Phase 3 Completed

123 enrolled 11 charts 1 FDA

Purpura, Thrombocytopenic, Idiopathic

NCT02076399 2019-02-12

FIT

Phase 3 Completed

76 enrolled 17 charts 1 FDA

Purpura, Thrombocytopenic, Idiopathic

NCT02076412 2019-01-25

FIT

Phase 3 Completed

74 enrolled 17 charts 1 FDA

Purpura, Thrombocytopenic, Idiopathic

NCT01444417 2017-02-09

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Phase 3 Completed

62 enrolled 16 charts 1 FDA

Classical hematology

Purpura, Thrombocytopenic, Thrombocytopenia, Purpura, Thrombocytopenic, Idiopathic